With a total iron‑binding capacity of 497 µg/dL, unsaturated iron‑binding capacity of 479 µg/dL, serum iron of 18 µg/dL, and transferrin saturation of 4 %, what is the likely diagnosis and how should it be managed?

Iron Deficiency Anemia: Diagnosis and Management

These laboratory values (TIBC 497 µg/dL, UIBC 479 µg/dL, serum iron 18 µg/dL, transferrin saturation 4%) are diagnostic of absolute iron deficiency anemia, and you should initiate oral iron supplementation while simultaneously investigating for an underlying source of blood loss, particularly gastrointestinal pathology. 1

Diagnostic Interpretation

Your patient's iron studies demonstrate classic absolute iron deficiency:

• Transferrin saturation of 4% is severely reduced (normal 15-55%), indicating inadequate iron delivery to erythroid marrow 1
• Serum iron of 18 µg/dL is markedly low (normal 27-159 µg/dL), confirming depleted circulating iron 1
• Elevated TIBC (497 µg/dL) and UIBC (479 µg/dL) reflect the body's compensatory attempt to mobilize any available iron stores 2
• A transferrin saturation below 15% with these findings defines absolute iron deficiency 1

Check serum ferritin immediately if not already done—a ferritin <45 µg/L confirms iron deficiency with 85% sensitivity and 92% specificity 1. If ferritin is <15 µg/L, this indicates completely depleted iron stores 1.

Mandatory Evaluation for Blood Loss

In postmenopausal women and all adult men with iron deficiency anemia, bidirectional endoscopy (both upper endoscopy and colonoscopy) is mandatory to exclude gastrointestinal malignancy and other bleeding sources 1. This should be performed even if the patient is asymptomatic, as gastrointestinal pathology is found in a significant proportion of these patients 1.

Before endoscopy, obtain:

• Complete blood count to assess hemoglobin and mean corpuscular volume 1
• Renal function (creatinine, GFR) since chronic kidney disease alters iron deficiency interpretation and management 1
• C-reactive protein to exclude inflammation that might affect ferritin interpretation 1
• Celiac serology (tissue transglutaminase antibodies) as celiac disease impairs iron absorption 1

In premenopausal women, assess menstrual blood loss patterns, but do not assume menstruation is the sole cause without excluding gastrointestinal pathology if anemia is severe (hemoglobin <100 g/L) 1.

Iron Replacement Strategy

First-Line: Oral Iron Therapy

Initiate oral iron supplementation immediately with 100-200 mg elemental iron daily 1. Common formulations include:

• Ferrous sulfate 325 mg (65 mg elemental iron) taken 2-3 times daily
• Ferrous gluconate or ferrous fumarate as alternatives if sulfate is not tolerated 1

Administer oral iron on alternate days rather than daily if gastrointestinal side effects occur, as daily dosing increases hepcidin levels that block iron absorption 1. Take iron on an empty stomach when possible, avoiding concurrent use of proton pump inhibitors or H2-blockers that impair absorption 1.

When to Use Intravenous Iron

Switch to intravenous iron if:

• No hemoglobin response (increase <1 g/dL) after 4 weeks of oral iron 1
• Intolerable gastrointestinal side effects (nausea, constipation, abdominal pain) 1
• Malabsorption conditions are present (celiac disease, inflammatory bowel disease) 1
• Chronic kidney disease with GFR <60 mL/min/1.73m² 1
• Chronic heart failure (oral iron shows no prognostic benefit in this population) 1

Available IV iron preparations include ferric carboxymaltose, iron sucrose, ferumoxytol, iron isomaltoside, and low molecular weight iron dextran 1. Avoid high molecular weight iron dextran due to anaphylaxis risk 1.

Special Considerations

If Chronic Kidney Disease is Present

Different diagnostic thresholds apply: absolute iron deficiency in CKD is defined as transferrin saturation ≤20% with ferritin ≤100 µg/L (predialysis/peritoneal dialysis) or ≤200 µg/L (hemodialysis) 1. Your patient's 4% transferrin saturation meets these criteria regardless of ferritin level 1.

If Inflammation is Present

Ferritin up to 100 µg/L may still represent iron deficiency in inflammatory states 1. Consider checking soluble transferrin receptor or reticulocyte hemoglobin content if ferritin is 30-100 µg/L with elevated CRP 1.

Monitoring Response

Recheck hemoglobin after 4 weeks of oral iron therapy 1. An adequate response is a hemoglobin increase of ≥1 g/dL 1. Continue iron supplementation for 3-6 months after hemoglobin normalizes to replenish iron stores 1.

Monitor for recurrent iron deficiency every 3 months for at least one year after correction, particularly in patients with inflammatory bowel disease or ongoing blood loss 1.

Critical Pitfall to Avoid

Do not delay gastrointestinal evaluation while treating with iron—the primary goal is identifying and treating the underlying cause of blood loss, not just correcting the anemia 1. Malignancy detection takes priority over symptom management, as this directly impacts mortality 1.